To further explore the translational value of NE inhibition in prevention of atherosclerosis, a highly potent, selective, intracellular, orally bioavailable, and long‐duration HNE inhibitor, GW311616A,15 was orally administered to WT (NE+/+/ApoE−/−) mice. The gene discussed is APOE; the disease is atherosclerosis.